 LEXINGTON, Mass. and AMSTERDAM, Nov. 04, 2020 GLOBE NEWSWIRE -- uniQure N.V. NASDAQ: QURE, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that four data presentations, including one oral presentation and three poster presentations, will be delivered at the 62nd American Society of Hematology ASH Annual Meeting, which will be held December 5-8 as a virtual event. 